2017 was a year for the record books at the Patent Trials and Appeal Board (PTAB), which has included newly created standard operating procedures from the PTAB, a landmark en banc ruling from the Court of Appeals for the Federal Circuit impacting amendment practice, and a series of informative decisions from PTAB impacting multiple proceedings … Continue reading this entry
Tags: amendment, aqua, en banc, generic ipr, ipr stats, oil states, pharmaceutical ipr, ptab, sovereign immunity, supreme court, year in review